The pmrF polymyxin-resistance operon of Yersinia pseudotuberculosis is upregulated by the PhoP-PhoQ two-component system but not by PmrA-PmrB, and is not required for virulence The Yersinia pseudotuberculosis chromosome contains a seven-gene polycistronic unit (the pmrF operon) whose products share extensive homologies with their pmrF counterparts in Salmonella enterica serovar Typhimurium (S. typhimurium), another Gram-negative bacterial enteropathogen. This gene cluster is essential for addition of 4-aminoarabinose to the lipid moiety of LPS, as demonstrated by MALDI-TOF mass spectrometry of lipid A from both wild-type and pmrF-mutated strains. As in S. typhimurium, 4-aminoarabinose substitution of lipid A contributes to in vitro resistance of Y. pseudotuberculosis to the antimicrobial peptide polymyxin B. Whereas pmrF expression in S. typhimurium is mediated by both the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems, it appears to be PmrA-PmrB-independent in Y. pseudotuberculosis, with the response regulator PhoP interacting directly with the pmrF operon promoter region. This result reveals that the ubiquitous PmrA-PmrB regulatory system controls different regulons in distinct bacterial species. In addition, pmrF inactivation in Y. pseudotuberculosis has no effect on bacterial virulence in the mouse, again in contrast to the situation in S. typhimurium. The marked differences in pmrF operon regulation in these two phylogenetically close bacterial species may be related to their dissimilar lifestyles.
INTRODUCTION
Cationic peptides (typically containing 30-40 amino acid residues) are important effectors of innate immunity of both plants and animals to microbes (Hancock & Scott, 2000) . To date, several hundred antimicrobial peptides have been identified in nature and classified into different groups according to their structure. Two families have been extensively studied: the first (of which defensins are the prototype representatives) consists of molecules stabilized by one or several intramolecular disulphide bridges, whereas the second includes a-helix-folded compounds such as cecropins, magainins or melittin. Due to their common cationic and amphipathic properties, antimicrobial peptides are able to bind easily to negatively charged microbial membranes. However, their mode of action may dramatically differ from one class of compounds to another: some peptides may alter bacterial membrane integrity by solubilization or pore formation, whereas others are able to translocate across these membranes in order to access and inhibit intracellular targets (Hancock & Rozek, 2002; Wu et al., 1999) . Microbial pathogens must thus have evolved distinct mechanisms for resisting such a broad range of peptide effectors (Devine & Hancock, 2002; Wu et al., 1999) . Antimicrobial peptide resistance mechanisms in the Gram-negative facultative intracellular bacterial pathogen Salmonella enterica serovar Typhimurium (S. typhimurium) have been extensively studied. In this species, a seven-gene polycistronic unit (pmrHFIJKLM, the pmrF operon) plays an essential role in resistance to polymyxin: at least six of the seven pmrF operon genes are necessary for the 3These authors contributed equally to this work.
Abbreviation: MALDI-TOF, matrix assisted laser desorption ionizationtime of flight.
The GenBank/EMBL/DDBJ accession numbers for the Y. pseudotuberculosis pmrF, phoP-phoQ and pmrA-pmrB operons are AF336802, AF333125 and AY259243 respectively. biosynthesis and export of 4-deoxy-4-amino-L-arabinose (hereafter referred to as 4-aminoarabinose) and esterification of the 49 phosphate group of lipid A with this amino sugar -a modification which contributes to a reduction in the net negative charge of lipid A (Groisman et al., 1997; Gunn et al., 1998 Gunn et al., , 2000 . In Salmonella, transcriptional activation of this operon requires the PmrA-PmrB twocomponent regulatory system, where PmrB is the integral membrane sensor kinase that responds to high Fe 3+ levels and PmrA is the cognate regulatory protein that controls pmrF operon expression directly (Wosten & Groisman, 1999) . The PmrA-PmrB system is encoded by the pmrCAB operon, where the pmrC gene has recently been shown to mediate substitution of lipid A with phosphoethanolamine (Lee et al., 2004) . A decrease in extracellular Mg 2+ concentration (i.e. from the usual millimolar range down to micromolar levels) also promotes PmrA-dependent upregulation of the pmrF operon. This process additionally requires the PhoP (regulator)-PhoQ (sensor) two-component regulatory system . PhoP positively controls the pmrF operon at the transcriptional level by increasing production of PmrD (an 85 amino acid polypeptide), which then activates the PmrA protein (Kox et al., 2000; Roland et al., 1994) .
It has been reported that the Gram-negative enteropathogen Yersinia pseudotuberculosis (a member of the Enterobacteriaceae related to Salmonella) is highly resistant to polymyxin and a-helical peptides (Bengoechea et al., 1998a, b) . In Yersinia pestis (a clone that recently emerged from Y. pseudotuberculosis: Achtman et al., 1999) , it has been shown that this resistance is controlled by PhoP-PhoQ (Oyston et al., 2000) and probably depends on the production of 4-aminoarabinose (Rebeil et al., 2004) . In the present work, we confirm the crucial role of a Salmonella-like pmrF operon in the control of resistance of Y. pseudotuberculosis to certain classes of antimicrobial peptides. However, this operon may play a role in cellular processes other than those allowing survival in mammals, and its two-componentsystem-mediated expression differs from that of the corresponding Salmonella chromosomal locus.
METHODS
Bacterial strains and growth conditions. The main characteristics of the bacterial strains and plasmids used in this study are listed in Table 1 . Escherichia coli DH5a was used as a host for the cloning experiments. E. coli SY327lpir and SM10lpir were recipients for replication of suicide plasmids. Y. pseudotuberculosis, S. typhimurium and E. coli strains were grown at 28 uC, 37 uC and 37 uC, respectively, in Luria-Bertani (LB) broth or on agar plates. Mating experiments between E. coli and Y. pseudotuberculosis were plated on M9 minimum medium agar, as described previously (Carnoy et al., 2000) . Ampicillin (100 mg ml ) and sucrose (10 %) were added to media for bacterial selection when necessary. IPTG (1 mM) and XGal (200 mg ml 21 ) were used for blue/white colony screening.
Nucleic acid manipulations. Standard procedures were used for genomic DNA extraction, small-scale plasmid preparation, endonuclease digestion, DNA ligation, agarose gel electrophoresis, elution of DNA fragments and E. coli transformation (Sambrook & Russell, 2001 ). Large-scale plasmid DNA preparations were purified on Qiagen columns. Recombinant plasmid DNA was introduced into Y. pseudotuberculosis by mating or electroporation (Conchas & Carniel, 1990 Synthetic oligonucleotides and PCR. Oligonucleotide primers (Table 2) were custom-synthesized (Sigma and Genset) for PCR generation of DNA fragments used for cloning or probing. PCR amplification was performed as described elsewhere (Sebbane et al., 2001) with AmpliTaq Gold polymerase (Perkin Elmer Applied Biosystems). Digoxigenin-labelled PCR products were generated with the PCR DIG Labelling Mix (Roche Diagnostics) and purified on Dye-ex Spin columns or Qiaquick PCR purification kit (Qiagen).
Mutagenesis. Gene inactivation in Y. pseudotuberculosis was performed by exchange of the wild-type gene with its inactivated allele through homologous recombination using a suicide plasmid. Briefly, we engineered pUC18 plasmid derivatives containing a deleted copy of the gene or DNA region of interest. Each construct was obtained by fusing PCR fragments yielded by amplification of the target gene's upstream and downstream flanking regions with, respectively, the 59 and 39 ends of an antibiotic (Km or Tet) resistance gene. DNA inserts were then subcloned into the suicide vector pCVD442. Mutants were selected after mating the Y. pseudotuberculosis wild-type strain with E. coli lpir harbouring recombinant suicide plasmids (see Table 1 ). Mutant genotypes were confirmed by PCR and Southern blot hybridization with appropriate DNA probes (data not shown). Random Tn5 mutagenesis of Y. pseudotuberculosis cells was performed by mating the recipient strain with the donor strain E. coli SM10 lpir harbouring the recombinant suicide vector pMS90 as described previously (Riot et al., 1997) .
Lipid A extraction and MALDI-TOF mass spectrometry analysis. Lipid A was isolated as previously described (Zhou et al., 1999) . Briefly, an overnight culture grown at 37 uC on LB was centrifuged and the cell pellet was then washed once with PBS. Cells were resuspended in 0?8 ml PBS, and a single-phase Bligh/Dyer mixture was made by addition of 2 ml methanol and 1 ml chloroform. After 60 min at room temperature, the insoluble material was collected by centrifugation for 20 min. The pellet was washed once with 5 ml of a fresh, single-phase Bligh/Dyer mixture consisting of chloroform/ methanol/water (1 : 2 : 0?8, by vol.) and was then dispersed in 1?8 ml 12?5 mM sodium acetate (pH 4?5) containing 1 % SDS; the mixture was boiled for 30 min in order to cleave the glycosidic bond between lipid A and KDO. Lipid A was recovered by converting the hydrolysed material into a two-phase Bligh/Dyer mixture by addition of 2 ml On: Sun, 26 May 2019 11:09:14 chloroform and 2 ml methanol. After low-speed centrifugation, the lower phase was collected and washed twice with 4 ml of the upper phase derived from a fresh, neutral, two-phase chloroform/ methanol/water (2 : 2 : 1?8, by vol.) Bligh/Dyer mixture. The washed lower phase was dried under nitrogen.
MALDI-TOF mass spectroscopy analyses of lipid A were performed with the Bruker-Reflex III two-stage reflection time-of-flight mass analyser (Bruker Daltonics) in a linear TOF configuration with an acceleration voltage of 20 kV. Details of the methods used are given by Lindner (2000) . Mass scale calibration was performed externally with similar compounds of known chemical structure.
Purification of His-tagged recombinant PhoP proteins under native conditions. The recombinant E. coli strain harbouring pQE60PhoH6.2 was grown in 1 litre of LB medium supplemented with ampicillin (100 mg ml
21
) and kanamycin (25 mg ml 21 ). When the OD 600 reached 0?8, expression of the gene encoding the recombinant protein was induced with 1 mM IPTG for 0?5 h. The cells were harvested by centrifugation and then resuspended in 5 ml of lysis buffer (300 mM NaCl, 50 mM Na 2 HPO 4 , 10 mM imidazole, pH 8) per g fresh weight. Cells were lysed using a French press with a pressure of 1000 p.s.i. (approx 7 MPa). The lysate was clarified by centrifugation at 10 000 g for 20 min. The supernatant was filtered on a 0?45 mm filter before being loaded onto a 1 ml HiTrap Affinity column (Amersham) pre-equilibrated with lysis buffer. The column was washed first with 10 ml lysis buffer and then with 5 ml lysis buffer containing 50 mM imidazole. Elution was performed with 10 ml lysis buffer containing 250 mM imidazole. The collected fractions were analysed by SDS-PAGE, using a 12?5 % polyacrylamide gel and Coomassie blue staining. Samples were dialysed overnight against PBS/10 % (v/v) glycerol, dispensed into aliquots and stored at 220 uC.
Electrophoretic mobility shift assays. The binding of purified PhoP(His) 6 protein to PCR products from gene promoter regions was assessed by electrophoretic mobility shift assays, as previously described (Himpens et al., 2000) .
Antimicrobial peptide activity assays. Polymyxin B and cecropin B were purchased from Sigma; defensin A was purified from Phormia terranovae (a kind gift from P. Bullet). The formulation of the incubation medium was identical to that of RPMI 1640 (Invitrogen, ref. 21870) except for Ca(NO 3 ) 2 and MgSO 4 , which were added separately at appropriate concentrations. The bactericidal effects of antimicrobial peptides were determined using Y. pseudotuberculosis cells obtained from cultures in LB broth (which naturally contains iron) at 28 uC for 16-18 h (OD 620 0?4) followed by an additional 3 h incubation in LB broth at the appropriate temperature and in the presence of 300 mM of the iron chelators deferoxamine mesylate or 2,29-dipyridyl (Sigma) when necessary. Bactericidal assays were performed as follows. First, stock solutions of cecropin B, polymyxin B and defensin A (0?1 mg ml 21 in sterile distilled water) were diluted in the incubation medium at the appropriate concentrations. Then 100 ml volumes of these working solutions of defined peptide concentration were placed in each well of a 96-well microtitre plate. Ten microlitres of Y. pseudotuberculosis cell suspension was added to each well (final bacterial concentration 5610 6 c.f.u. ml
). As a control, bacterial suspensions were concomitantly added to wells containing 100 ml incubation medium lacking added antimicrobial peptides. Microtitre plates were shaken gently for 30 s and then incubated at 37 uC for 2 h. To assess viability of Y. pseudotuberculosis, 50 ml of mixture from each well was serially diluted in sterile distilled water. Diluates were plated on LB and incubated at 28 uC for 48-72 h. Bacterial survival was defined as the ratio of the number of viable bacteria after 2 h contact with peptides to the number of viable bacteria in the absence of peptides. Micrococcus luteus (highly sensitive to defensins) and S. enterica serovar Typhimurium strain LT2 were used as internal controls for defensin A and iron chelator (deferoxamine mesylate or 2,29-dipyridyl) activity respectively.
Experimental infection in a mouse model. Six-week-old female outbred OF1 mice (Iffa Credo) were challenged either by the intravenous (i.v.) route (0?3 ml bacterial suspension in sterile PBS) or by the intragastric (i.g.) route (0?2 ml bacterial suspension in sterile distilled water, using a gastric tube). Mice were starved for 18 h prior to gastric inoculation. Bacterial inocula were prepared from overnight cultures in LB at 28 uC. The cultures were centrifuged and the bacterial pellets were washed once and resuspended in distilled water or PBS. Animals were kept in positive-pressure cabinets during experimentation, and mortality was monitored daily for 21 days after challenge. For each experimental infection, the presence of the virulence plasmid pYV was confirmed by PCR on bacterial thermolysates using primers YOPH1 and YOPH2, which are internal to yopH, a gene located on pYV (Carnoy et al., 2000) . Infected animals were monitored for 3 weeks, and the 50 % lethal dose (LD 50 ) was calculated from groups of 5 (i.v. model) or 10 (i.g. model) mice according to the method of Reed & Muench (1938) . We first performed in silico analysis of the genome of Y. pestis CO92 (Parkhill et al., 2001) , a strain which is genetically closely related to Y. pseudotuberculosis (Achtman et al., 1999) . This investigation revealed the presence of a chromosomal locus of seven genes, apparently organized into an operon and displaying significant similarities with the Salmonella pmrF operon, i.e. 49-78 % identity at the protein level for the pmrH, pmrF, pmrI, pmrG, pmrK and pmrL genes respectively, and 37 % for the last one, pmrM, which makes a less obvious contribution (if any) to 4-aminoarabinose biosynthesis and export in Salmonella (Gunn et al., 2000) . PCR analysis of Y. pseudotuberculosis 32777 DNA with primers designed from the Y. pestis CO92 pmrF sequence confirmed that a pmrF-like locus was indeed present in this species. As expected, its nucleotide sequence (GenBank accession no. AF336802) was more than 98 % identical to that of Y. pestis. By analogy with Salmonella, we hypothesized that this locus might also contribute to substitution of lipid A with 4-aminoarabinose in Y. pseudotuberculosis and might, as a consequence, play a role in bacterial resistance to a-helical antimicrobial peptides. To verify this hypothesis, we inactivated the second gene of the operon (pmrF, whose product is necessary for 4-aminoarabinose substitution on bactoprenol phosphate and its subsequent export through the inner membrane) in wild-type strain 32777 and then compared the mutant's lipid A composition and susceptibility to antimicrobial peptides with those of the parent. MALDI-TOF mass spectrometry analysis of lipid A extracted from the wildtype and mutant strains (Fig. 1) confirmed that the pmrF locus was involved in addition of 4-aminoarabinose to lipid A. Inactivation of pmrF was associated with a decrease in bacterial resistance to both cecropin B and polymyxin B, and the magnitude of the reduction varied almost linearly with the peptide dose (Fig. 2) . This deficiency was fully restored after trans-complementation with the pmrF wild-type gene (Fig. 2) . In contrast, susceptibility to the insect defensin A did not change when the pmrF gene was inactivated, whatever the antimicrobial peptide concentration used in the assay.
Unlike PhoP-PhoQ, the PmrA-PmrB two-component regulatory system is not essential for activation of the Y. pseudotuberculosis pmrF operon Mg 2+ /Ca 2+ and Fe 3+ cation limitations (as well as pH) influence the ability of Salmonella to resist polymyxin (Garcia Groisman et al., 1997; Wosten et al., 2000) . We tested whether these environmental cues could also have an impact on the transcription of the pmrF operon in Y. pseudotuberculosis. As in Salmonella, a low (1 mM) Mg 2+ /Ca 2+ concentration and a pH decrease from 8 to 6 were both found to induce polymyxin resistance (Fig. 3a) . Transcription of the pmrF operon in Y. pseudotuberculosis was found to increase accordingly, by a factor of 7 and 2?5 for the Mg 2+ /Ca 2+ ion starvation and acidic pH conditions respectively (Fig. 3b) , as determined by slot blot densitometry analysis. In contrast to Salmonella, no reduction in polymyxin resistance was observed when Y. pseudotuberculosis cells were incubated with the iron chelators deferoxamine mesylate (Fig. 3a) or 2,29-dipyridyl (data not shown); nor did we see an increase in peptide resistance in the presence of an excess of ferric chloride. Similar results were noted with the a-helical peptide cecropin B at 3?25 mg ml 21 (data not shown). Finally, as depicted . The prominent peak detected at m/z 1823 may correspond to a hexa-acylated molecular species containing two glucosamines, two phosphates, four OH-C 14 , one C 12 : 0 and one C 16 : 1 , whereas the one obtained at m/z 2060 is consistent with a hepta-acylated form following the addition of C 16 : 0 to the hexa-acyl molecule. Peaks at m/z 1953 and at m/z 2191 are compatible with 4-aminoarabinose substitution on hexa-acylated and hepta-acylated lipid A, respectively. In lipid A from the pmrF mutant strain 32777DPmrF (b), the peak at m/z 1953 is close to the background level whereas the peak at m/z 2191 was not detected. Similar peaks at m/z 2060 in both strains show that hepta-acylation is pmrF-independent.
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On: Sun, 26 May 2019 11:09:14 Fig. 2 . Role of the pmrF locus in resistance of Y. pseudotuberculosis to various antimicrobial peptides. Wild-type strain 32777 and the isogenic pmrF (the second gene of the pmrF operon) mutant 32777DPmrF were incubated at 37 6C in RPMI with various amounts of the antimicrobial peptides polymyxin B, cecropin B and defensin A. Bacterial survival was assessed after a 2 h incubation period. Each bar (white for wild-type, black for pmrF mutant, hatched for trans-complemented mutant) represents the mean value (±SD) of five independent experiments. pmrF inactivation was associated with decreased bacterial survival versus 2?5 mg ml "1 polymyxin B or cecropin B. Complementation of mutant 32777DPmrF with pmrF in trans (plasmid pF12) fully restored the resistance of Y. pseudotuberculosis to 2?5 mg ml "1 concentrations of these two antimicrobial peptides. . Bacterial survival after 2 h contact with the antimicrobial peptide is depicted. Each bar (white for the wild-type strain, dashed for the pmrA mutant, grey for the phoP mutant) represents the mean value (±SD) of five independent assays. No resistance inductions were observed in either condition with the pmrF mutant. As a control assay, the resistance of S. typhimurium LT2 to polymyxin B was assessed under identical conditions: antimicrobial peptide resistance was found to increase sixfold and eightfold at low Mg 2+ /Ca 2+ ion concentrations and at pH 6 respectively, and was decreased tenfold when the assay was performed using iron-depleted medium (data not shown). (b) Total RNAs (10 mg) extracted from bacteria incubated for 30 min in medium free of antimicrobial peptide were spotted onto nitrocellulose membranes and hybridized with a digoxigenin-labelled 600 bp pmrF probe. A 16S rRNA probe from Y. pseudotuberculosis was used as a control for constitutive gene expression (data not shown). No signal was detected when RNA samples were pre-treated with RNase before hybridization. Experiments were repeated three times and representative results are shown.
in Fig. 3(b) , pmrF transcription was found not to require iron. Taken together, these results suggest that the pmrF locus is regulated differently in Y. pseudotuberculosis when compared to Salmonella. In this latter bacterium, ironmediated regulation of the pmrF locus is controlled by the PmrA-PmrB two-component system (Wosten et al., 2000) . Two corresponding tandemly arranged open reading frames (YPO3507 and YPO3508, whose products exhibit 56?4 and 50?4 % identity with the Salmonella PmrA and PmrB proteins respectively) have been identified in the Y. pestis CO92 genome. As expected, homologue genes with 99?5 and 99?4 % identity at the nucleotide level were also found in Y. pseudotuberculosis 32777 (GenBank accession no. AY259243). In line with a possible contribution to iron sensing, Y. pseudotuberculosis PmrB contains two ExxE iron receptor motifs at positions 30-33 and 55-58 (in the periplasmic loop) -just like its Salmonella or Erwinia carotovora counterparts (which are able to sense iron: Hyytiäinen et al., 2003; Wosten et al., 2000) but unlike PmrB from Pseudomonas aeruginosa (which apparently lacks this tetrapeptide and does not exhibit iron-sensing activity: McPhee et al., 2003) . We engineered a non-polar mutation in the Y. pseudotuberculosis pmrA gene and assessed pmrF expression in the mutant relative to wildtype under two different in vitro conditions (iron starvation and pH 6). As shown in Fig. 3(b) , transcription of this operon in the pmrA mutant did not differ from that of the wild-type strain in either case, and inactivation either of pmrB alone or of both genes encoding this twocomponent system yielded identical results. We thus conclude that the PmrA-PmrB two-component system is not essential for pmrF transcriptional activation in Y. pseudotuberculosis -at least under the in vitro conditions established for Salmonella. Whether or not the Y. pseudotuberculosis PmrA-PmrB two-component system responds to iron levels remains to be established experimentally.
However, transcription of the Y. pseudotuberculosis pmrF operon was also found to be induced upon Mg 2+ and Ca 2+ ion starvation (Fig. 3b) -consistent with the fact that lipid A substitution with 4-aminoarabinose is mediated by the PhoP-PhoQ two-component system (Rebeil et al., 2004) . Hence, it is possible that the pmrF operon was still under the control of PhoP-PhoQ but was independent of PmrAPmrB. To verify this hypothesis, we assessed the impact of a phoP knock-out mutation on the transcription level of the pmrF operon when bacteria were in an acidic (pH 6) environment or exposed to low concentrations of Mg 2+ / Ca 2+ or Fe 3+ ions. As depicted in Fig. 3(b) , PhoP inactivation was associated with a reduction in pmrF transcript production by a factor of between 3 and 20, depending on the bacterial growth conditions. This result indicates that the PhoP-PhoQ two-component system is essential for efficient expression of the pmrF operon. DNA mobility shift assays with purified, His-tagged PhoP protein revealed that PhoP binds to the pmrF operon promoter region (Fig. 4) , strongly suggesting that PhoP regulates pmrF operon transcription directly.
PhoP is the only detectable transcriptional regulator controlling expression of the Y. pseudotuberculosis pmrF operon
To search for other transcriptional regulators involved in the regulation of the pmrF operon, we used wild-type strain 32777 to construct a lacZ null mutant (strain 27RB1), which was next trans-complemented with plasmid pMM501, a pACYC184 derivative carrying the lacZ gene under the control of the pmrF operon's promoter region. Screening for pmrF activators was performed by Tn5 transposon insertional mutagenesis of Y. pseudotuberculosis strain 27RB1(pMM501) and isolation of mutants on X-Gal agar. Of the three million Tn5 mutants generated over ten experiments, 65 simultaneously formed pale blue colonies on selective agar and exhibited decreased resistance (ranging from 50-to 200-fold) to polymyxin B. Sequencing of the 200 bp upstream and downstream of the Tn5 insertion site revealed that the transposon had disrupted the phoP or phoQ gene in 60 mutants. In the remaining five, Tn5 was found to be inserted within an ORF whose product was highly homologous (82?2 % amino acid identity) to that of the E. coli miaA gene. Rather than encoding a transcriptional regulator as such, miaA produces a protein that A 353 bp fragment encompassing the putative pmrF operon promoter region was PCR-generated with primers UNK70 and BTU449E. The figure shows electrophoretic mobilities of the 32 P-labelled 353 bp fragment alone (lane 1), mixed with 0?1, 0?5, 1 and 2 mg purified PhoP(His) 6 (lanes 2, 3, 4 and 5, respectively) and mixed with 2 mg purified PhoP(His) 6 and a 100-fold excess of nonspecific DNA (lane 6) or a 50-fold excess of the same 353 bp unlabelled pmrF operon promoter region (lane 7). As an internal control of the electrophoretic mobility shift assay, PhoP(His) 6 was found to bind to the 32 P-labelled promoter region of the Y.
pseudotuberculosis phoP gene; this binding was not observed after addition of a 50-fold excess of unlabelled pmrF promoter region (data not shown). The positions of the well (W), complexed DNA (C) and free DNA (F) are indicated on the left of the figure. As illustrated, PhoP binds specifically to the 353 bp DNA segment encompassing the putative promoter of the pmrF operon.
acts at the post-transcriptional level by allowing tRNA maturation (Caillet & Droogmans, 1988) . We also explored the possibility that the pmrF operon might be under the control of a repressor. The same experimental strategy was thus used to identify potential negative regulators, although here Tn5 mutagenesis was carried out on a phoP mutant from strain 27RB1(pMM501). Tn5 mutants were screened on X-Gal agar for their capacity to give blue colonies darker than those yielded by the parental PhoP 2 strain. Using this approach, we were not able to isolate any repressors other than one displaying 44 % amino acid identity with the E. coli LacI repressor. These white-to-blue reverting mutants displayed similar polymyxin resistance to that of the 27RB1(pMM501) phoP mutant, suggesting that mutation of this lacI-like gene caused derepression of a regulon required for sugar metabolism (possibly lactose) rather than derepression of the pmrF operon.
The pmrF operon is not required for full virulence of Y. pseudotuberculosis in a mouse model
Antimicrobial peptides are major effectors of innate immunity in mammals, and so we investigated whether the pmrF operon contributes to the progression of host infection by Y. pseudotuberculosis. The virulence of the pmrF mutant was assessed in the OF-1 mouse. The Y. pseudotuberculosis pmrF mutant was found to be as virulent as the parental strain when administered intravenously (LD 50 <10
2 ). Its LD 50 also did not differ significantly from that of the wild-type in an oral model of infection, and the kinetics of animal death were similar, regardless of the infecting strain -again, in contrast to the situation in Salmonella (Gunn et al., 2000) .
DISCUSSION
The absence of 4-aminoarabinose and the high susceptibility to antimicrobial peptides in Y. pestis phoP mutants (Rebeil et al., 2004) had already suggested that of all the possible PhoP-regulated elements, it is this sugar moiety which is particularly involved in resistance of Y. pseudotuberculosis to antimicrobial peptides. In this work, we provide direct evidence that the Y. pseudotuberculosis pmrF operon plays a major role in bacterial resistance in vitro to killing by polymyxin B and at least some a-helical antimicrobial peptides (cecropin B), but is not needed for insect defensin tolerance. A contribution to polymyxin resistance was previously reported for the Salmonella pmrF gene cluster (Gunn et al., 1998) . In the pathogenic yersiniae, the pmrF operon is inserted between the btuCDE operon (required for the passage of vitamin B 12 through the outer and inner bacterial membranes (de Veaux et al., 1986) and the nplC gene (encoding a putative lipoprotein of unknown function). An identical genetic organization was described very recently in the insect pathogen Photorhabdus luminescens (Derzelle et al., 2004) . In contrast, btu and nplC homologue genes are clustered on the Salmonella chromosome, at some distance (985 kb) from the pmrF operon. As in Ps. aeruginosa (Moskowitz et al., 2004) , the pmrD gene (which flanks the right extremity of the Salmonella pmrF operon and encodes a pmrA activator) was not found in the immediate vicinity of the Y. pseudotuberculosis pmrF operon, and subsequent whole-genome in silico analysis revealed that the gene was missing in the micro-organism studied here.
In S. typhimurium, pmrF transcription is mediated by both the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems but is only under the control of PhoP-PhoQ in Y. pseudotuberculosis. In line with this result, PhoP was found to participate directly in the transcriptional activation of this operon in the latter species. This situation is similar to what was observed in Ps. aeruginosa (McPhee et al., 2003) , although both two-component systems are suspected to control pmrF expression in this latter organism. It is noteworthy that no putative Salmonella-, Ps. aeruginosa-or E. coli-like phoP promoter-binding direct repeats were found upstream of either the pmrF or phoPQ operons. A lack of conserved motifs in these promoting regions has also been observed in Ph. luminescens (Derzelle et al., 2004) .
Y. pseudotuberculosis PmrA and PmrB exhibit relatively low levels of identity (56 and 51 %, respectively) with the respective homologous proteins in Salmonella, thus raising the possibility that the two Y. pseudotuberculosis and Salmonella PmrA-PmrB systems may not in fact be homologues. Interestingly, this situation is very similar to that recently observed in Er. carotovora, where the PmrA and PmrB subunits (Hyytiainen et al., 2003) share only 59 % and 56 % protein identity with their respective Salmonella counterparts and 65 % and 58 % with those of Y. pseudotuberculosis. Just as in Salmonella, the Erwinia PmrB protein is likely to be able to sense iron as an input signal directly, as illustrated by the presence of conserved iron-receptor-like EXXE motifs. However, in Er. carotovora, the PmrA-PmrB system functions differently and, moreover, has been shown to regulate virulence functions specific to plant pathogens, in addition to antimicrobial peptide resistance (Hyytiäinen et al., 2003) . These observations strongly suggest that this two-component system has diverged differently in these three species, contrasting with 'core' systems like OmpREnvZ, which remain highly conserved (i.e. >90 % identical). The CtrA-CtrB two component system has recently been shown to regulate distinct pathways (and thus different genes) in Brucella abortus and Caulobacter crescentus, despite the high degree of homology (>80 % identity at the amino acid level) for the corresponding regulator subunits in these two species (Bellefontaine et al., 2002) . PmrAPmrB is thus a second example showing that a ubiquitous two-component regulatory system may control different regulons in different bacterial species.
What, then, might be the role of PmrA-PmrB? In Yersinia, this system is probably involved in regulation of genes other than those contributing to lipid A substitution with 4-aminoarabinose. In contrast to Salmonella, E. coli and Er. carotovora, the Yersinia pmrA and pmrB genes are not associated with pmrC to form the pmrCAB operon -in fact, pmrC is probably absent from the Yersinia genome (Chain et al., 2004) . Instead, as judged by the presence of a very short intergenic region (5 nucleotides), pmrA and pmrB are putatively co-transcribed with dacB, which encodes a product 79 % identical to an E. coli penicillin-binding DD-carboxypeptidase/DD-endopeptidase (Korat et al., 1991) . This latter finding suggests that PmrA-PmrB could be involved in peptidoglycan homeostasis in Yersinia cells. Fully annotated genome sequences of pathogenic yersiniae are either available now (for Y. pestis and Y. pseudotuberculosis) or will be released soon (for Y. enterocolitica): transcriptome analysis of pmrA and pmrB mutants and their parental counterparts should clarify this point.
As shown in Fig. 3(b) , pmrF transcription responds to pH changes, and our results indicate that this regulation was PmrA-PmrB-independent. As already mentioned by other workers, the PhoP-PhoQ system is unlikely to participate in this process either . Accordingly, a (twofold) pH-induced transcriptional activation was still observed in a phoP-null background (Fig. 3) , suggesting that an additional regulator may control pmrF expression. To identify other potential activators or repressors, Tn5 transposon mutagenesis was carried out in Y. pseudotuberculosis. The regulation mutants isolated (other than phoP and phoQ mutants) were all found to have a transposon copy inserted within the miaA gene. The miaA product is a tRNA N 6 -isopentenyladenosine synthetase involved in the first step of the transformation of the adenosine located at position 37 (ms 2 i 6 A37) of some tRNAs into 2-methyl-N 6 -isopentenyladenosine. Recently, this tRNA modification was found to be essential for optimal expression of virulence factors in the bacterial pathogens Agrobacterium tumefaciens and Shigella flexneri (Durand et al., 1997; Gray et al., 1992) . In the latter organism, it has been reported that a miaA mutant displayed a tenfold reduction in transcription of the virF regulon due to a post-transcriptional downregulation of VirF activator expression (Durand et al., 2000) . miaA inactivation in Y. pseudotuberculosis was associated with a slight inhibition of bacterial growth (as in Sh. flexneri). Transcription of the pmrF operon in two independent mutants (which differed only in the orientation of Tn5 within miaA) was significantly reduced, although it was not as low as that obtained in Y. pseudotuberculosis phoP mutants (data not shown). The exact mechanism of this unexpected additional control of pmrF operon transcription is unknown. However, the dramatic decrease in phoP mRNA levels in these insertion mutants (unpublished data) suggests that MiaA might modulate expression of the pmrF operon via regulation of PhoP -either by controlling the production of a regulator that mediates phoPQ transcription or by interfering with autoregulation of the PhoP-PhoQ system. These hypotheses are currently undergoing further investigation. However, to the best of our knowledge, MiaA activity has yet to be reported as being pH-dependent: therefore, we assume that MiaA per se is unlikely to account for the pH-dependence of pmrF transcription, and that other pmrFregulating elements exist. Failure to detect putative regulatory elements by transposon mutagenesis could be due to the deleterious effects of inactivation on the bacterial cell or, alternatively, to a very low frequency of Tn5 intragenic insertion.
pmrF inactivation attenuates Salmonella virulence when bacteria are administered by an oral route (Gunn et al., 2000) . In contrast, we found that arabinosylation of LPS had no detectable effect on the oral pathogenicity of Y. pseudotuberculosis in a mouse model. This discrepancy might be partly explained by the distinctly different lifestyles of the two enteropathogens in the host. Following oral ingestion, Salmonella cells enter the intestinal mucosa and then are taken up by (and survive within) resident phagocytes. Bacterial survival and replication in these cells depend, at least in part, on resistance (through lipid A modification of LPS) to killing by antimicrobial peptides (Gunn et al., 2000) . Like Salmonella, Y. pseudotuberculosis is an enteroinvasive pathogen but after having crossed the epithelial barrier, it resists attack by mucosal macrophages via a plasmid-encoded type III secretion process (Cornelis, 2002) , thus blocking phagocytosis.
Growth of Y. pseudotuberculosis at temperatures below 37 u C results in increased resistance to polymyxin B, consistent with previous Yersinia studies showing that temperature downshifts are associated with higher levels of incorporation of 4-aminoarabinose into lipid A (Bhagya Lakshmi et al., 1989; Kawahara et al., 2002) . Nevertheless, we found that transcription of the Y. pseudotuberculosis pmrF operon was abolished at low temperatures (M. Marceau and others, unpublished results). Upregulation of lipid A substitution must therefore occur at a post-transcriptional level by an as yet unknown, cold-induced regulatory mechanism. The existence of such a mechanism (designed to counterbalance reduced transcription levels of the pmrF operon) strongly suggests that lipid A modifications may also play a crucial role outside the mammalian host.
